Molecular Diagnostics: Market Size, Segmentation, Growth and OpportunitiesDeciBio
February 15, 2012
116 Pages - SKU: DCB3790026
More Diagnostics reports by DeciBio
Fluidigm Due Diligence: Company Profile and Market Opportunity by DeciBio
Fluidigm is a life science company that develops and distributes instruments, chips and reagents primarily for genomic analysis. The company owns a disruptive and scalable ...
Molecular Diagnostics: Market Segmentation and Opportunities by DeciBio
Molecular diagnostics (MDx) is a class of diagnostic tests that identify nucleic acids such as DNA. These nucleic acids can be genetic material of foreign ...
Life Sciences Research Tools Market by DeciBio
This report provides an overview of the life sciences research tools market from 2005 to 2015. Life sciences research tools companies offer instruments and reagents ...
Qiagen Due Diligence: Company Profile, SWOT Analysis and Market Opportunity by DeciBioSee all reports like this >>
Qiagen (NASDAQ: QGEN) develops and markets biological sample preparation and analysis products for academic, biopharmaceutical and molecular diagnostics companies. These products are considered gold standards ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
- The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
- Global Molecular Diagnostics Market 2012-2016
- Global Biochips Market 2012-2016
- Analysis of the Global In Vitro Diagnostics Market